| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Friday - Aug 25, 2023 |
|||||||||
|
The Gap
GAP
|
- | $0.32 | $0.09 | $3.55B | $3.58B |
NYSE |
|||
| - | $1.73 | $1.80 | $491.09M | $483.41M |
NYSE |
||||
|
Akebia Therapeutics
AKBA
|
Q2 FY23 | -$0.06 | -$0.03 | $56.38M | $59.10M |
NASDAQ |
|||
|
ArrowMark Financial
BANX
|
- | $1.28 | $0.57 | $13.54M | $6.45M |
NASDAQ |
|||
|
Ebang International Holdings Inc.
EBON
|
- | -$1.25 | - | $4.09M | - |
NASDAQ |
|||
|
Biomerica
BMRA
|
- | -$0.11 | $0.32 | $1.11M | $3.10M |
NASDAQ |
|||
|
60 Degrees Pharmaceuticals
SXTP
|
- | -$0.66 | $0.17 | $100K | $100K |
NASDAQ |
|||
|
Renovaro Biosciences
RENB
|
- | -$3.64 | - | - | - |
NASDAQ |
|||
|
ArriVent BioPharma
AVBP
|
- | -$0.64 | - | - | - |
NASDAQ |
|||
